STOCK TITAN

CONMED (CON) trusts detail 130,000-share planned sale and recent large stock trades

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CONMED Corporation affiliated trusts filed to permit the potential sale of 130,000 shares of common stock through UBS Financial Services Inc., with an indicated aggregate market value of $4,114,500.00, against 127,961,780 shares outstanding as of August 3, 2026.

The shares proposed for sale were originally acquired via private purchases of stock on February 5, 1997, February 23, 2005, and April 29, 2005, totaling 38,544, 588, and 90,868 shares, respectively. The filing also lists recent sales by The Rocco A Ortenzio Trust FBO Robert Ortenzio and The Revocable Trust of Rocco A Ortenzio, including blocks of 130,000 and 259,940 shares of common stock between May 8, 2026 and July 1, 2026, for aggregate consideration up to $7,939,763.32 on a single date.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 130,000 shares Common stock to be sold through UBS Financial Services Inc.
Aggregate market value of proposed sale $4,114,500.00 Indicated value of 130,000 shares of common stock
Shares outstanding 127,961,780 shares Common stock outstanding as of August 3, 2026
Shares acquired 02/05/1997 90,868 shares Private Purchase of Stock from issuer on 02/05/1997
Shares acquired 04/29/2005 38,544 shares Private Purchase of Stock from issuer on 04/29/2005
Sale on 07/01/2026 by Revocable Trust 259,940 shares; $7,939,763.32 Common stock sold by The Revocable Trust of Rocco A Ortenzio
Sale on 05/08/2026 by FBO Robert Ortenzio Trust 130,000 shares; $3,250,000.00 Common stock sold by The Rocco A Ortenzio Trust FBO Robert Ortenzio
Sale on 06/01/2026 by FBO Robert Ortenzio Trust 130,000 shares; $3,250,026.00 Common stock sold by The Rocco A Ortenzio Trust FBO Robert Ortenzio
Form 144 regulatory
"144: Securities Information Common | UBS Financial Services Inc."
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Private Purchase of Stock financial
"Common | 04/29/2005 | Private Purchase of Stock | Issuer"
Revocable Trust financial
"The Revocable Trust of Rocco A Ortenzio DTD 08/14/07 As Amended"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
aggregate market value financial
"130000 | 4114500.00 | 127961780 | 08/03/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does CON (CONMED) disclose in this Form 144 filing?

The filing discloses a potential sale of 130,000 shares of CONMED common stock through UBS Financial Services Inc., with an aggregate market value of $4,114,500.00, relative to 127,961,780 shares outstanding as of August 3, 2026.

Who is selling CON (CONMED) shares and in what form are they held?

The shares are held by The Rocco A Ortenzio Trust FBO Robert Ortenzio and The Revocable Trust of Rocco A Ortenzio. These trusts report both a planned 130,000-share sale and several recent block sales of CONMED common stock.

How many CON (CONMED) shares are proposed to be sold under this Form 144?

The filing contemplates the potential sale of 130,000 shares of CONMED common stock, with an indicated aggregate market value of $4,114,500.00, through UBS Financial Services Inc. and listed on the NYSE.

What recent CON (CONMED) stock sales by the trusts are reported?

Reported transactions include multiple sales, such as 130,000 shares on May 8, June 1, and July 1, 2026, and a 259,940-share sale on July 1, 2026, with consideration amounts up to $7,939,763.32 on a single date.

When were the CON (CONMED) shares originally acquired by the trusts?

The shares proposed for sale were acquired through Private Purchase of Stock transactions from the issuer on 02/05/1997, 02/23/2005, and 04/29/2005, in blocks of 90,868, 588, and 38,544 shares, respectively.

What is the relationship between the proposed CON (CONMED) sale and total shares outstanding?

The proposed 130,000-share sale is measured against 127,961,780 CONMED common shares outstanding as of August 3, 2026; this outstanding figure serves as a baseline and is not being offered.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature